NCT00435045View on ClinicalTrials.gov

Evaluation of Efficacy and Safety of Omacor, Co-Administered With Atorvastatin, in Subjects With Hypertriglyceridemia

PHASE3CompletedINTERVENTIONAL

Enrollment

245

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions

Hypertriglyceridemia

Interventions

DRUG

Lovaza (omega-3-acid ethyl esters) [formerly known as Omacor] plus atorvastatin

Lovaza + atorvastatin

DRUG

atorvastatin

atorvastatin + placebo

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY